Cleveland Clinic Study Reveals Delayed Disability Progression in Non-Relapsing Secondary Progressive Multiple Sclerosis
A groundbreaking study led by the Cleveland Clinic presents promising results regarding tolebrutinib, an investigational oral Bruton’s tyrosine kinase (BTK) ...